Abstract
The need to broaden research directed at answering fundamental questions in HIV vaccine discovery through laboratory, nonhuman primate (NHP), and clinical research has recently been emphasized. In addition, the importance of attracting and retaining young researchers, developing better NHP models, and more closely linking NHP and clinical research is being stressed. In an era of a level budget for biomedical research at the U.S. National Institutes of Health (NIH), HIV/AIDS vaccine research efforts will need to be carefully prioritized such that resources to energize HIV vaccine discovery can be identified. This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities.
| Original language | English |
|---|---|
| Pages (from-to) | 530-532 |
| Number of pages | 3 |
| Journal | Science |
| Volume | 321 |
| Issue number | 5888 |
| DOIs | |
| State | Published - Jul 25 2008 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- General
Cite this
HIV vaccine research : The way forward. / Fauci, Anthony S.; Johnston, Margaret I.; Dieffenbach, Carl W.; Burton, Dennis R.; Hammer, Scott M.; Hoxie, James A.; Martin, Malcolm; Overbaugh, Julie; Watkins, David; Mahmoud, Adel; Greene, Warner C.
In: Science, Vol. 321, No. 5888, 25.07.2008, p. 530-532.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - HIV vaccine research
T2 - The way forward
AU - Fauci, Anthony S.
AU - Johnston, Margaret I.
AU - Dieffenbach, Carl W.
AU - Burton, Dennis R.
AU - Hammer, Scott M.
AU - Hoxie, James A.
AU - Martin, Malcolm
AU - Overbaugh, Julie
AU - Watkins, David
AU - Mahmoud, Adel
AU - Greene, Warner C.
PY - 2008/7/25
Y1 - 2008/7/25
N2 - The need to broaden research directed at answering fundamental questions in HIV vaccine discovery through laboratory, nonhuman primate (NHP), and clinical research has recently been emphasized. In addition, the importance of attracting and retaining young researchers, developing better NHP models, and more closely linking NHP and clinical research is being stressed. In an era of a level budget for biomedical research at the U.S. National Institutes of Health (NIH), HIV/AIDS vaccine research efforts will need to be carefully prioritized such that resources to energize HIV vaccine discovery can be identified. This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities.
AB - The need to broaden research directed at answering fundamental questions in HIV vaccine discovery through laboratory, nonhuman primate (NHP), and clinical research has recently been emphasized. In addition, the importance of attracting and retaining young researchers, developing better NHP models, and more closely linking NHP and clinical research is being stressed. In an era of a level budget for biomedical research at the U.S. National Institutes of Health (NIH), HIV/AIDS vaccine research efforts will need to be carefully prioritized such that resources to energize HIV vaccine discovery can be identified. This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities.
UR - http://www.scopus.com/inward/record.url?scp=48249134364&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=48249134364&partnerID=8YFLogxK
U2 - 10.1126/science.1161000
DO - 10.1126/science.1161000
M3 - Article
VL - 321
SP - 530
EP - 532
JO - Science
JF - Science
SN - 0036-8075
IS - 5888
ER -